Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and Acquired Immune Deficiency Syndrome

camptothecin has been researched along with Acquired Immune Deficiency Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smart, T1
Brady, JN; Doniger, J; Hung, CL; Palini, A; Pantazis, P; Radonovich, MF; Sadaie, MR; Snyder, SW1

Other Studies

3 other study(ies) available for camptothecin and Acquired Immune Deficiency Syndrome

ArticleYear
Making inroads on PML.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Camptothecin; HIV Protease Inhibitors; Humans; Irinotecan; Leukoencephalopathy, Progressive Multifocal; Topotecan

1996
PML update.
    Critical Path AIDS project, 1997,Summer, Issue:No 32

    Topics: Acquired Immunodeficiency Syndrome; Camptothecin; Clinical Trials, Phase II as Topic; Enzyme Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Topotecan

1997
9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.
    Journal of medical virology, 2001, Volume: 64, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Flow Cytometry; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphocytes; Reverse Transcriptase Inhibitors; Virus Replication

2001